Hemodynamic effects of a cardioselective beta-adrenergic inhibitor (ICi 50172) in coronary insufficiency. Preliminary results
Rosseau, M.; Vandenput, F.; Brasseur, L.
Acta Cardiologica 1972 Suppl 15: 239
1972
ISSN/ISBN: 0001-5385 PMID: 4147615 Document Number: 52778
Document emailed within 1 workday
Related Documents
Harms, H.H. 1976: Isoproterenol antagonism of cardioselective beta adrenergic receptor blocking agents: a comparative study of human and guinea-pig cardiac and bronchial beta adrenergic receptors Journal of Pharmacology and Experimental Therapeutics 199(2): 329-335Sterkowicz, S. 1973: Use of cardioselective beta adrenergic blockaders in the treatment of circulatory failure Polski Tygodnik Lekarski 28(26): 987-990
Sterkowicz, S.; Antczak, S.; Antczak, E. 1972: Use of cardioselective beta-adrenergic blockaders in supportive treatment of bronchial asthma Polski Tygodnik Lekarski 27(10): 387-389
Bory, M.; Pierron, F.; Panagides, D.; Massiani, P.F.; Yvorra, S.; Desfossez, L. 1993: Severe hyperkaliaemia induced by a non-cardioselective beta-adrenergic blocker and pheochromocytoma in a normotensive patient European Journal of Medicine 2(8): 506-508
Iskenderov, B.G.; Tatarchenko, I.P.; Shevyrev, V.A. 1999: Cardio-hemodynamic effects of domestic adrenergic beta-antagonist proxodolol in hypertension in patients with pacemaker Klinicheskaia Meditsina 77(4): 29-31
Mérillon, J.P.; Motte, G.; Leclerc, J.F.; Fruchaud, J.; Gourgon, R. 1977: Hemodynamic effects of sodium nitroprusside in the absence of coronary insufficiency Annales de Medecine Interne 128(6-7): 631-634
Böhm, M.; Castellano, M.; Agabiti-Rosei, E.; Flesch, M.; Paul, M.; Erdmann, E. 1995: Dose-dependent dissociation of ACE-inhibitor effects on blood pressure, cardiac hypertrophy, and beta-adrenergic signal transduction Circulation 92(10): 3006-3013
Maurette, P.; Dabadie, P.; Brulé, J.F.; Castagnera, L.; Stricker, A.; Chevais, R. 1985: Hemodynamic effects of naloxone in brain death (preliminary results) Agressologie: Revue Internationale de Physio-Biologie et de Pharmacologie Appliquees Aux Effets de l'Agression 26(1): 69-71
Mattioli, G.; Ricci, S.; Menozzi, A.; Teglio, V. 1982: Hemodynamic changes caused by beta-blocking agents with and without intrinsic sympathicomimetic activity and with and without cardioselective activity. Comparison of hypertensives at fixed and variable frequencies Minerva Cardioangiologica 30(3): 81-88
De Hert, S.G.; Van der Linden, P.J.; Broecke, P.W.; Rodrigus, I.E.; Sermeus, L.A.; Moulijn, A.C.; Gillebert, T.C. 1999: The effects of beta-adrenergic stimulation on the length-dependent regulation of myocardial function in coronary surgery patients Anesthesia and Analgesia 89(4): 835-842
Mauser, M.; Voelker, W.; Ickrath, O.; Hoffmeister, H.M.; Karsch, K.R. 1989: The acute hemodynamic effects of the new vasodilating beta blocker carvedilol in comparison with combined administration of nifedipine and propranolol in patients with coronary heart disease Zeitschrift für Kardiologie 78(11): 726-731
Di Luzio, V.; Purcaro, A.; Curzi, G.; Di Segni, E.; Chiesa, R.; Di Giuseppe, F. 1972: Effects on the contractile state of the myocardium and anti-arrhythmic properties of practolol, a beta-blocking agent with cardioselective activity Bollettino Della Societa Italiana di Cardiologia 17(3): 179-187
Caputo, R.P.; Giambartolomei, A.; Simons, A.; Reger, M.; Wagner, S.; Esente, P. 2001: Adjunctive therapies in the cath lab. use of combination glycoprotein IIb/IIIa inhibitor and direct thrombin inhibitor drugs to support percutaneous coronary stent placement in a patient with renal insufficiency and heparin-induced thrombocytopenia Journal of Invasive Cardiology 13(9): 657-660
Stauch, M.; Nissen, N.; Grewe, N. 1978: Comparative measurement of pulmonary artery pressure after meproscillarin and beta-methyldigoxin demonstrating their effects on the left bentricular function in patients with heart and coronary insufficiency Arzneimittel-Forschung 28(3a): 545-550
V'iuchnova, E.S.; Maev, I.V.; Merzlikin, L.A. 1995: The correction of the hemodynamic disorders in patients with IHD complicated by intraventricular blocks by using beta-adrenergic agents Terapevticheskii Arkhiv 67(2): 54-57
Shen, J.Q. 1981: Atenolol, a new beta-adrenergic blocking agent, in treatment of hypertension: therapeutic effect and hemodynamic changes Zhonghua Xin Xue Guan Bing Za Zhi 9(2): 94-98
Nakane, T.; Chiba, S. 1988: Comparative study of direct coronary vascular responses to diltiazem, adrenergic beta-blockers and other vasodilators in isolated, perfused dog and monkey coronary arteries Archives Internationales de Pharmacodynamie et de Therapie 291: 153-162
Yndgaard, S.; Lippert, F.K.; Berthelsen, P.G. 1998: Do cardioselective beta-antagonists block the cardiac beta-receptor function also in the long run? Ugeskrift for Laeger 160(18): 2706-2709
Nicod, P.; Goy, J.; Waeber, B.; Bussien, J.P.; Turini, G.A.; Nussberger, J.; Hofbauer, K.G.; Brunner, H.R. 1985: Hemodynamic effects of an inhibitor of the vascular effects of vasopressin in patients with congestive heart failure Schweizerische Medizinische Wochenschrift 115(50): 1823-1825
Zhong, H.; Minneman, K.P. 1993: Close reciprocal regulation of beta 1- and beta 2-adrenergic receptors by dexamethasone in C6 glioma cells: effects on catecholamine responsiveness Molecular Pharmacology 44(6): 1085-1093